Journal of Peking University (Health Sciences) ›› 2024, Vol. 56 ›› Issue (1): 144-149. doi: 10.19723/j.issn.1671-167X.2024.01.022

Previous Articles     Next Articles

Association of pregnancy factors with cow's milk protein allergy in infants

Yangyang LI,Lin HOU,Zijun MA,Shanyamei HUANG,Jie LIU*(),Chaomei ZENG,Jiong QIN   

  1. Department of Pediatrics, Peking University People's Hospital, Beijing 100044, China
  • Received:2022-10-31 Online:2024-02-18 Published:2024-02-06
  • Contact: Jie LIU E-mail:yy.lovej@163.com
  • Supported by:
    the 2018 Beijing Key Clinical Specialty Construction Project-Pediatrics(2199000726)

RICH HTML

  

Abstract:

Objective: To preliminarily explore the association of pregnancy factors with cow's milk protein allergy in infants. Methods: This study was based on data from a subcohort of a study called genetic susceptibility to cow's milk allergy in Chinese children, including infants born in Peking University People's Hospital between March 1, 2020, and December 31, 2020. The infants were divided into a cow's milk protein allergy (CMPA) group and a control group according to whether they had developed cow's milk protein allergy at the age of 1 year. We retrospectively collected the clinical data of infants and their mothers before and during pregnancy, and analyzed the association of multiple factors during pregnancy with cow's milk protein allergy in infants. Results: A total of 278 infants were enrolled in this study, including 52 infants with CMPA and 226 infants without CMPA. Among them, there were 143 boys and 135 girls. The proportion of male infants in the CMPA group (69.2%) was higher than that in the control group (47.3%), and the difference was statistically significant (P=0.004). There were no significant differences in the distribution of birth weight, gestational age at birth, low-birth-weight infants, premature, umbilical cord entangle neck, and neonatal asphyxia between the CMPA group and the control group (P>0.05). The proportion of mothers complicated with autoimmune diseases, anemia or antibiotics exposure during pregnancy in the CMPA group was higher than that in the control group, and there were statistical differences between the two groups (P < 0.05). There was no significant difference in the distribution of other pregnancy complications between the two groups (P>0.05), such as eclampsia/preeclampsia, chronic hypertension/gestational hypertension, diabetes/gestational diabetes, thyroid diseases, and so on. There was no significant difference in the overall distribution of some blood routine indexes during pregnancy between the CMPA group and the control group (P>0.05). Multivariate Logistic regression analysis showed that male infant, mothers complicated with autoimmune diseases or anemia, antibiotic exposure during pregnancy were independent risk factors for cow's milk protein allergy. Conclusion: Male infant, mothers complicated with autoimmune diseases or anemia, antibiotic exposure during pregnancy were independent risk factors for cow's milk protein allergy.

Key words: Cow's milk protein allergy, Risk factors, Infant, Pregnancy

CLC Number: 

  • R723.1

Table 1

Basic information of participants"

Items CMPA group (n=52) Control group (n=226) χ2/t/Z value P value
Gender, n(%)
    Male 36 (69.2) 107 (47.3) 8.106 0.004
    Female 16 (30.8) 119 (52.7)
Birth weight/g, $\bar x \pm s$ 3 113.4±675.0 3 153.1±533.5 0.46 0.646
Birth weight/g, $\bar x \pm s$ 3 113.4±675.0 3 153.1±533.5 0.460 0.646
Low-birth-weight infant, n(%) 9 (17.3) 25 (11.1) 1.536 0.215
Gestational age/weeks, M(P25, P75) 38.9 (37.7, 39.7) 39.1 (37.9, 40.1) 1.366 0.172
Premature, n(%) 12 (23.1) 42 (18.6) 0.545 0.460
Umbilical cord entangle neck, n(%) 1 (1.9) 8 (3.5) 0.025 0.873
Neonatal asphyxia, n(%) 2 (3.8) 4 (1.8) 0.160 0.689

Table 2

Association of maternal prepregnancy factors with CMPA in offsprings"

Maternal factors CMPA group (n=52) Control group (n=226) χ2/t value P value
Age/years, $\bar x \pm s$ 33.0±4.1 32.7±4.2 0.446 0.656
Ethnic groups, n(%)
    Han 44 (84.6) 205 (90.7) 1.679 0.195
    Other ethnic groups 8 (15.4) 21 (9.3)
Prepregnancy BMI/(kg/m2), n(%)
     < 18.5 3 (5.8) 28 (12.4) 6.049 0.109
    18.5-24.9 42 (80.8) 153 (67.7)
    25.0-29.9 3 (5.8) 34 (15.0)
    ≥30 4 (7.7) 11 (4.9)
Previous pregnancy, n(%)
    None 33 (63.5) 117 (51.8) 2.326 0.127
    ≥1 19 (36.5) 109 (48.2)
Paritya, n(%)
    None 40 (76.9) 149 (65.9) 2.348 0.125
    ≥1 12 (23.1) 77 (34.1)
Histories of abnormal pregnancy and delivery, n(%)
    No 51 (98.1) 212 (93.8) 0.790 0.374
    Yes 1 (1.9) 14 (6.2)

Table 3

Association of maternal pregnancy factors with CMPA in offsprings[n(%)]"

Maternal factors CMPA group (n=52) Control group (n=226) χ2 value P value
IVF-ET a 8 (15.4) 30 (13.3) 0.160 0.690
Cesarean delivery 14 (26.9) 84 (37.2) 1.944 0.163
Hospitalization frequency b
    1 39 (75.0) 181 (80.1) 0.663 0.416
    ≥2 13 (25.0) 45 (19.9)
Eclampsia/preeclampsia 2 (3.8) 19 (8.4) 0.691 0.406
Chronic hypertension/gestational hypertension 9 (17.3) 22 (9.7) 2.447 0.118
Diabetes/gestational diabetes 8 (15.4) 35 (15.5) 0.000 0.985
Thyroid disease 7 (13.5) 36 (15.9) 0.197 0.657
Oligohydramnios 4 (7.7) 22 (9.7) 0.037 0.848
Autoimmune disease 9 (17.3) 18 (8.0) 4.208 0.040
Hypoproteinemia 1 (1.9) 9 (4.0) 0.094 0.760
Anemia 26 (50.0) 65 (28.8) 8.660 0.003
Antibiotics during pregnancy 12 (23.1) 25 (11.1) 5.289 0.021

Table 4

Association of maternal blood routine indicators during pregnancy with CMPA in offsprings"

Maternal factors CMPA group (n=52) Control group (n=224) t/Z value P value
WBC/(×109/L), $\bar x \pm s$ 9.2±2.1 9.1±1.8 0.267 0.789
NE/(×109/L), $\bar x \pm s$ 6.8±1.8 6.7±1.5 0.460 0.646
NE/%, $\bar x \pm s$ 72.5±6.0 72.2±4.8 0.386 0.700
LY/(×109/L), $\bar x \pm s$ 1.8±0.4 1.8±0.4 0.490 0.625
LY/%, $\bar x \pm s$ 19.9±5.3 20.1±4.3 0.359 0.720
NLR, $\bar x \pm s$ 4.2±1.3 4.0±1.2 0.952 0.342
MO/(×109/L), $\bar x \pm s$ 0.57±0.13 0.58±0.14 0.367 0.714
MO/%, $\bar x \pm s$ 6.4±1.3 6.4±1.3 0.230 0.818
LMR, $\bar x \pm s$ 3.2±0.9 3.3±0.9 0.381 0.703
PLR, $\bar x \pm s$ 130.4±44.4 124.6±34.6 1.021 0.308
EO/(×109/L), M(P25, P75) 0.07 (0.03, 0.12) 0.07 (0.05, 0.11) 0.682 0.495
EO/%, M(P25, P75) 0.83 (0.48, 1.19) 0.78 (0.55, 1.19) 0.201 0.841
BA/(×109/L), $\bar x \pm s$ 0.03±0.02 0.03±0.01 0.411 0.682
BA/%, $\bar x \pm s$ 0.35±0.13 0.39±0.11 0.133 0.894

Table 5

Multivariate analysis of risk factors for CMPA"

Risk factors B SE Wald χ2 P OR 95%CI
Malea 0.972 0.343 8.011 0.005 2.643 1.348-5.179
Autoimmune diseaseb 1.109 0.475 5.442 0.020 3.031 1.194-7.693
Anemiab 0.899 0.326 7.599 0.006 2.458 1.297-4.657
Antibiotics during pregnancy 0.868 0.416 4.349 0.037 2.383 1.054-5.388
1 Venter C , Arshad SH . Epidemiology of food allergy[J]. Pediatr Clin North Am, 2011, 58 (2): 327- 349.
doi: 10.1016/j.pcl.2011.02.011
2 陈静, 廖艳, 张红忠, 等. 三城市两岁以下儿童食物过敏现状调查[J]. 中华儿科杂志, 2012, 50 (1): 5- 9.
doi: 10.3760/cma.j.issn.0578-1310.2012.01.002
3 Prescott SL . Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseases[J]. J Allergy Clin Immunol, 2013, 131 (1): 23- 30.
doi: 10.1016/j.jaci.2012.11.019
4 Chen Y , Zhu J , Lyu J , et al. Association of maternal prepregnancy weight and gestational weight gain with children's allergic diseases[J]. JAMA Netw Open, 2020, 3 (9): e2015643.
doi: 10.1001/jamanetworkopen.2020.15643
5 Rosa MJ , Lee AG , Wright RJ . Evidence establishing a link between prenatal and early-life stress and asthma development[J]. Curr Opin Allergy Clin Immunol, 2018, 18 (2): 148- 158.
doi: 10.1097/ACI.0000000000000421
6 韦茹, 王静, 杨延萍, 等. 婴幼儿牛奶蛋白过敏的临床特点与危险因素分析[J]. 实用医学杂志, 2019, 35 (21): 3322- 3326.
doi: 10.3969/j.issn.1006-5725.2019.21.012
7 杨秀梅. 婴幼儿牛奶蛋白过敏的临床特点与危险因素分析[J]. 中国保健营养, 2021, 31 (14): 43.
8 姚家瑜, 邹国新, 胡红梅. 80例牛奶蛋白过敏婴幼儿的临床表现及触发因素分析[J]. 中国实用医药, 2022, 17 (5): 69- 71.
9 Hou L , Ma Z , Chao S , et al. Genetic susceptibility to cow's milk allergy in Chinese children[J]. Asia Pac J Clin Nutr, 2022, 31 (1): 147- 155.
10 Venter C , Brown T , Meyer R , et al. Better recognition, diagnosis and management of non-IgE-mediated cow's milk allergy in infancy: iMAP, an international interpretation of the MAP (Milk Allergy in Primary Care) guideline[J]. Clin Transl Allergy, 2017, 7, 26.
doi: 10.1186/s13601-017-0162-y
11 Erre GL , Paliogiannis P , Castagna F , et al. Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis[J]. Eur J Clin Invest, 2019, 49 (1): e13037.
doi: 10.1111/eci.13037
12 Patel B , Oye M , Norez D , et al. Peripheral blood lymphocyte-to-monocyte ratio as a screening marker for influenza infection[J]. J Investig Med, 2021, 69 (1): 47- 51.
doi: 10.1136/jim-2020-001335
13 Huang Z , Fu Z , Huang W , et al. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis[J]. Am J Emerg Med, 2020, 38 (3): 641- 647.
doi: 10.1016/j.ajem.2019.10.023
14 Mousan G , Kamat D . Cow's milk protein allergy[J]. Clin Pediatr (Phila), 2016, 55 (11): 1054- 1063.
doi: 10.1177/0009922816664512
15 Flom JD , Sicherer SH . Epidemiology of cow's milk allergy[J]. Nutrients, 2019, 11 (5): 1051.
doi: 10.3390/nu11051051
16 王念蓉. 儿童食物过敏的预后及影响因素研究[J]. 国际儿科学杂志, 2008, 35 (5): 460- 462.
doi: 10.3760/cma.j.issn.1673-4408.2008.05.023
17 张纪泳, 周少明, 王少华, 等. 婴儿牛奶蛋白过敏的危险因素: 多中心调查分析[J]. 中国当代儿科杂志, 2020, 22 (1): 42- 46.
18 Metsälä J , Lundqvist A , Virta LJ , et al. Mother's and offspring's use of antibiotics and infant allergy to cow's milk[J]. Epidemio-logy, 2013, 24 (2): 303- 309.
19 Jakobsson HE , Jernberg C , Andersson AF , et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome[J]. PLoS One, 2010, 5 (3): e9836.
doi: 10.1371/journal.pone.0009836
20 Bedford Russell AR , Murch SH . Could peripartum antibiotics have delayed health consequences for the infant?[J]. BJOG, 2006, 113 (7): 758- 765.
doi: 10.1111/j.1471-0528.2006.00952.x
21 Ji C , Zhang G , Xu S , et al. Antibiotic treatments to mothers during the perinatal period leaving hidden trouble on infants[J]. Eur J Pediatr, 2022, 181 (9): 3459- 3471.
doi: 10.1007/s00431-022-04516-6
22 Zhang H , Zhang Z , Liao Y , et al. The Complex link and disease between the gut microbiome and the immune system in infants[J]. Front Cell Infect Microbiol, 2022, 12, 924119.
23 Jenmalm MC . The mother-offspring dyad: Microbial transmission, immune interactions and allergy development[J]. J Intern Med, 2017, 282 (6): 484- 495.
doi: 10.1111/joim.12652
24 Triche EW , Lundsberg LS , Wickner PG , et al. Association of maternal anemia with increased wheeze and asthma in children[J]. Ann Allergy Asthma Immunol, 2011, 106 (2): 131- 139.
doi: 10.1016/j.anai.2010.11.007
25 Alcalay I, Wainstock T, Sheiner E. Maternal anemia and long-term respiratory morbidity of the offspring: Results of a population-based cohort [J]. Arch Gynecol Obstet, 2022, 9(2022-09-21)[2022-10-11]. https://pubmed.ncbi.nlm.nih.gov/36129519.
26 Kumfer AM , Commins SP . Primary prevention of food allergy[J]. Curr Allergy Asthma Rep, 2019, 19 (1): 7.
27 Pali-Schöll I , Renz H , Jensen-Jarolim E . Update on allergies in pregnancy, lactation, and early childhood[J]. J Allergy Clin Immunol, 2009, 123 (5): 1012- 1021.
28 Sardecka I , Łoś-Rycharska E , Ludwig H , et al. Early risk factors for cow's milk allergy in children in the first year of life[J]. Allergy Asthma Proc, 2018, 39 (6): e44- e54.
[1] Hui WEI, Jingfeng ZHANG, Zhongqiang YAO, Jinxia ZHAO. Clinical characteristics and relevant factors of rheumatoid arthritis patients with anemia of chronic disease [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 307-312.
[2] Jie ZHAO, Chun FU, Xiujuan ZHAO, Haiyan XUE, Shu LI, Zhenzhou WANG, Fengxue ZHU. Risk factors for ventilator-associated pneumonia in patients with chest trauma in intensive care unit [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 351-358.
[3] Xinyi LI, Jinxia ZHAO, Rong MU. Impact of aspirin use on pregnancy outcomes in patients with systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1074-1080.
[4] Ping ZHENG, Kunhong LIN, Mengyuan LIU, Xuyan ZHAO, Yangxin XIAO, Yan XING. A follow-up study on the physical and motor development of premature infants with small for gestational age within 2 years after birth [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1124-1131.
[5] Xiaoyi JIA, Yan ZHANG, Weihong TANG. Diagnostic value of fecal calprotectin detection in infants with milk protein-allergic enteritis [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1132-1135.
[6] Bowen LI, Qiang ZHANG, Yixin SUN. Establishment and validation of a risk prediction model for scoliosis after Nuss procedure in children and young adults with pectus excavatum [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 941-946.
[7] Xiaoyong YANG, Fan ZHANG, Lulin MA, Cheng LIU. Clinical characteristics and influencing factors of extraglandular invasion of prostatic ductal adenocarcinoma [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 956-960.
[8] Wei LIU, Wen GUO, Zhe GUO, Chunyan LI, Yunlong LI, Siqi LIU, Liang ZHANG, Hui SONG. Risk factors associated with non-radiographic bone erosion in patients with gout [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 735-739.
[9] Rui LI, Jing PAN, Qing YANG, Yan XING, Xiaomei TONG. Impact of donor human milk bank on clinical outcomes in infants with very/extremely low birth weight [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 759-763.
[10] Mengxi LU, Qiuping LIU, Tianjing ZHOU, Xiaofei LIU, Yexiang SUN, Peng SHEN, Hongbo LIN, Xun TANG, Pei GAO. Association of triglyceride-glucose index and cardiovascular disease in a community-based Chinese cohort [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 430-435.
[11] Chang LIU, Zhao LI, Lei JIN, Chunyi LIU, Chunjing WANG, Jie ZHANG, Lei JIN. Association between maternal periconceptional supplementation of folic acid or multiple micronutrients containing folic acid and perinatal mortality rate [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 473-480.
[12] Shuhan YANG, Yixin LI, Haoliang CUI, Youxin WANG, Yuying WU, Mingyue WANG, Yifan YANG, Nur Enkar, Lei YANG, Hui WANG. Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic risk factor abnormalities with adverse pregnancy outcomes [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 487-495.
[13] Wen BIAN, Wenjun ZHOU, Tianchen WU, Peijing ZHU, Yinuo CHEN, Pengbo YUAN, Xueju WANG, Ying WANG, Yuan WEI, Yangyu ZHAO. Perinatal outcomes of single intrauterine fetal demise in monochorionic diamniotic twins [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 592-598.
[14] Wenqiong WANG, Yuke HOU, Chun LI, Xuewu ZHANG. Predictors of adverse pregnancy outcomes in patients with systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 599-603.
[15] Junjuan YANG, Lei ZHANG, Yan ZHANG. Pregnancy complicated by patent urachus: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 393-395.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!